Primary prevention drug therapy: can it meet patients’ requirements for reduced risk?
Llewellyn-Thomas HA, Paterson JM, Carter JA, Basinski A, Myers MG, Hardacre GD, Dunn EV, D'Agostino RB, Wolf PA, Naylor CD. Med Decis Making. 2002; 22(4):326-39.
Llewellyn-Thomas HA, Paterson JM, Carter JA, Basinski A, Myers MG, Hardacre GD, Dunn EV, D'Agostino RB, Wolf PA, Naylor CD. Med Decis Making. 2002; 22(4):326-39.
Guttman M, Slaughter PM, Theriault ME, DeBoer DP, Naylor CD. Can J Neurol Sci. 2002; 29(3):221-6.
Ray JG, Mamdani MM, Yeo EL. Thromb Haemost. 2002; 88(2):205-9.
Jackevicius CA, Mamdani M, Tu JV. JAMA. 2002; 288(4):462-7.
Tu K, Mamdani MM, Tu JV. Amer J Med. 2002; 113(1):52-8.
Dhalla IA, Anderson GM, Mamdani MM, Bronskill SE, Sykora K, Rochon PA. J Am Geriatr Soc. 2002; 50(6):995-1000.
Etminan M, Levine MA, Tomlinson G, Rochon PA. Amer J Med. 2002; 112(8):642-6.
Kaiser AS, Ferris LE, Pastuszak AL, Llewellyn-Thomas H, Johnson JA, Conacher S, Shaw BF. J Obstet Gynaecol. 2002; 22(3):246-55.
Mamdani MM, Tu K, Austin PC, Alter DA. Ann Pharmacother. 2002; 36(5):804-8.
Paterson JM, Llewellyn-Thomas HA, Naylor CD. Health Expect. 2002; 5(1):3-15.